BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

464 related articles for article (PubMed ID: 26975739)

  • 1. Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial.
    Canavese G; Bruzzi P; Catturich A; Tomei D; Carli F; Garrone E; Spinaci S; Lacopo F; Tinterri C; Dozin B
    Ann Surg Oncol; 2016 Aug; 23(8):2494-500. PubMed ID: 26975739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial.
    Canavese G; Catturich A; Vecchio C; Tomei D; Gipponi M; Villa G; Carli F; Bruzzi P; Dozin B
    Ann Oncol; 2009 Jun; 20(6):1001-7. PubMed ID: 19174453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study.
    Veronesi U; Paganelli G; Viale G; Luini A; Zurrida S; Galimberti V; Intra M; Veronesi P; Maisonneuve P; Gatti G; Mazzarol G; De Cicco C; Manfredi G; Fernández JR
    Lancet Oncol; 2006 Dec; 7(12):983-90. PubMed ID: 17138219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection.
    Schulze T; Mucke J; Markwardt J; Schlag PM; Bembenek A
    J Surg Oncol; 2006 Feb; 93(2):109-19. PubMed ID: 16425290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection.
    Kuijt GP; van de Poll-Franse LV; Voogd AC; Nieuwenhuijzen GA; Roumen RM
    Eur J Surg Oncol; 2007 Sep; 33(7):832-7. PubMed ID: 17197151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Optimal treatment of the axilla after positive sentinel lymph node biopsy in early invasive breast cancer. Early results of the OTOASOR trial].
    Sávolt A; Musonda P; Mátrai Z; Polgár C; Rényi-Vámos F; Rubovszky G; Kovács E; Sinkovics I; Udvarhelyi N; Török K; Kásler M; Péley G
    Orv Hetil; 2013 Dec; 154(49):1934-42. PubMed ID: 24292111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is axillary lymph node dissection necessary after sentinel lymph node biopsy in patients with mastectomy and pathological N1 breast cancer?
    Fu Y; Chung D; Cao MA; Apple S; Chang H
    Ann Surg Oncol; 2014 Dec; 21(13):4109-23. PubMed ID: 25081336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.
    Reitsamer R; Peintinger F; Prokop E; Menzel C; Cimpoca W; Rettenbacher L
    Eur J Surg Oncol; 2003 Apr; 29(3):221-3. PubMed ID: 12657230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Axillary treatment for operable primary breast cancer.
    Bromham N; Schmidt-Hansen M; Astin M; Hasler E; Reed MW
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004561. PubMed ID: 28052186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial.
    Zavagno G; De Salvo GL; Scalco G; Bozza F; Barutta L; Del Bianco P; Renier M; Racano C; Carraro P; Nitti D;
    Ann Surg; 2008 Feb; 247(2):207-13. PubMed ID: 18216523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of axillary lymph node dissection after sentinel lymph node biopsy on overall survival in patients with T1 or T2 node-positive breast cancer: report from the Korean Breast Cancer Society.
    Park HS; Chae BJ; Song BJ; Jung SS; Han W; Nam SJ; Youn HJ; Ko BK; Kim DW;
    Ann Surg Oncol; 2014 Apr; 21(4):1231-6. PubMed ID: 24318094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sentinel lymph node biopsy after previous axillary surgery: A review.
    Kothari MS; Rusby JE; Agusti AA; MacNeill FA
    Eur J Surg Oncol; 2012 Jan; 38(1):8-15. PubMed ID: 22032909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer.
    Crane-Okada R; Wascher RA; Elashoff D; Giuliano AE
    Ann Surg Oncol; 2008 Jul; 15(7):1996-2005. PubMed ID: 18415650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is there any benefit from sentinel lymph node biopsy using the combined radioisotope/dye technique in breast cancer patients with clinically negative axilla?
    Koukouraki S; Sanidas E; Askoxilakis J; Stathaki M; Charalambakis V; Daboudi M; Voutoufianaki I; Kafousi M; Stathopoulos E; Tsiftsis D; Karkavitsas N
    Nucl Med Commun; 2009 Jan; 30(1):48-53. PubMed ID: 19020472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer.
    Bilimoria KY; Bentrem DJ; Hansen NM; Bethke KP; Rademaker AW; Ko CY; Winchester DP; Winchester DJ
    J Clin Oncol; 2009 Jun; 27(18):2946-53. PubMed ID: 19364968
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sentinel lymph node biopsy after neoadjuvant chemotherapy in patients with node-positive breast cancer: guiding a more selective axillary approach.
    Damin AP; Zancan M; Melo MP; Biazus JV
    Breast Cancer Res Treat; 2021 Apr; 186(2):527-534. PubMed ID: 33165710
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility and oncological safety of sentinel node biopsy in breast cancer patients with a local recurrence.
    Biglia N; Bounous VE; Gallo M; Fuso L; Sgro LG; Maggiorotto F; Ponzone R
    Breast; 2018 Oct; 41():8-13. PubMed ID: 29933180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy compared with axillary lymph node dissection in early breast cancer: a meta-analysis.
    Wang Z; Wu LC; Chen JQ
    Breast Cancer Res Treat; 2011 Oct; 129(3):675-89. PubMed ID: 21743996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A longitudinal comparison of arm morbidity in stage I-II breast cancer patients treated with sentinel lymph node biopsy, sentinel lymph node biopsy followed by completion lymph node dissection, or axillary lymph node dissection.
    Kootstra JJ; Hoekstra-Weebers JE; Rietman JS; de Vries J; Baas PC; Geertzen JH; Hoekstra HJ
    Ann Surg Oncol; 2010 Sep; 17(9):2384-94. PubMed ID: 20221902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.